We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Varian Medical Systems Earns Top Marks in Oncology IT Study

By HospiMedica staff writers
Posted on 07 Aug 2008
Varian Medical Systems, Inc. More...
(Palo Alto, CA,USA) was ranked first in an independent study released last week by Klas (Orem, UT, USA), a research firm that specializes in monitoring and reporting on the performance of healthcare vendors. Varian's Aria software, an information system for managing medical and radiation oncology practices, received top scores in study categories including: ease of use, quality of releases and updates, and compatibility with third-party products.

According to the June 2008 Oncology report, Varian Medical Systems is "considered by many providers to have the most developed and comprehensive oncology solution." The report additionally stated, "many Varian customers feel that the Aria suite is the most robust solution for medical and radiation oncology available on the market today."

Although Klas interviewed 11 potential vendors, only three had a sufficient number of active installations to qualify. Varian was the only vendor to score above the group average in all four of the report's major categories: product/technology indicators, service indicators, success indicators, and business indicators. Varian scored above competitors in 23 of the 40 indicators that the study measured. Some of the indicators for which Varian achieved top scores included: ease of use; quality of releases or updates; technology that is easy to implement and support; works with third-party producers; quality of implementation, training, and documentation; quality and timeliness of interfaces; helping job performance, and overall satisfaction with vendor/product.

All of the CIOs, managers, doctors, nurses, information technology (IT) directors, and other administrators and healthcare professionals surveyed about their experience with Varian's oncology information system reported that they consider Varian's system part of their organization's long-term plan, that they would buy Varian's product again, and would recommend Varian's product to a friend or peer.

The Klas study predicted that Varian would continue to be seen as one of the most complete medical and radiation oncology systems for some time to come. "We're gratified to receive top marks in an objective survey of our customers," said Dow Wilson, president of the company's Oncology Systems business. "It validates the work we're doing to offer treatment centers a versatile set of best-in-class clinical tools for fighting cancer."

Varian Medical Systems is a world-leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy, and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers, and medical oncology practices. Varian is also a major supplier of tubes and digital detectors for X-ray imaging in medical, scientific, and industrial applications as well as X-ray imaging products for cargo screening and industrial inspection.

Klas is a research firm specializing in monitoring and reporting the performance of healthcare vendors.


Related Links:
Varian Medical Systems
Klas

Gold Member
12-Channel ECG
CM1200B
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
VTE Prevention System
Flowtron ACS900
New
Instrument Cabinet
TRZY-068
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: New clinical guidance suggests treatments to prevent blood clots in CLTI patients after leg artery procedures (Photo courtesy of Shutterstock)

Stronger Blood Clot Prevention Measures Needed After Leg Artery Procedures in High-Risk Patients

Chronic limb-threatening ischemia (CLTI), the most severe form of peripheral artery disease (PAD), significantly reduces blood flow to the legs and feet. Despite undergoing lower limb revascularization... Read more

Surgical Techniques

view channel
Image: The milli-spinner can shrink blood clots without rupturing them (Photo courtesy of Andrew Brodhead/Stanford)

New Technology More Than Doubles Success Rate for Blood Clot Removal

In cases of ischemic stroke, where a blood clot obstructs oxygen supply to the brain, time is critical. The faster the clot is removed and blood flow restored, the more brain tissue can be saved, improving... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: A research collaboration aims to further advance findings in human genomics research in cardiovascular diseases (Photo courtesy of 123RF)

Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies

A research collaboration will focus on the joint discovery of novel therapeutic approaches based on findings in human genomics research related to cardiovascular diseases. Bayer (Berlin, Germany) and... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.